Trial access to Reaxys Medicinal Chemistry (RMC)
Reaxys Medicinal Chemistry covers the intersection between the informational spaces of small molecules and bioactivity. Mediating the relationships in this intersection are the drug candidates and the druggable targets biological pathways, tissues, cell lines, organisms and bioassays that were used to test hit and lead compounds.
The Trial ends on August 30, 2019.
Please send feedback to the library
